Le Lézard
Classified in: Health
Subject: AWD

Irene Chatoor, M.D., is recognized by Continental Who's Who


WASHINGTON, Dec. 11, 2017 /PRNewswire/ -- Irene Chatoor, M.D., is recognized by Continental Who's Who as a Pinnacle Professional Member in the field of Mental Health and Psychiatry in recognition of her role as Vice Chair of the Department of Psychiatry for Children's National Health System.             

Renowned for their expertise in the medical industry, Children's National Health System was rated number one for their knowledge in intensive newborn care. With a team of well trained professionals certified in various facets of the medical industry, the team at Children's National are specialized in offering their patients the quality care that they deserve in several areas ranging from Cardiology and Cardiac Surgery to Neurology, Neurosurgery and Oncology.

Vice Chair of Psychiatry at Children's National Health System, Dr. Chatoor has been in the industry since 1976. Amassing over forty years of experience and twenty seven years of experience in her current role as Vice Chair, Dr. Chatoor specializes in all facets of mental health care and psychiatry. Assisting children and their families in the development of healthy eating habits, Dr. Chatoor specializes in the areas of feeding disorders in regards to the infant population.

Professor of Psychiatry and Pediatrics at the George Washington University, Dr. Chatoor is an advocate in early childhood feeding and eating interventions. A renowned international speaker  across the areas of Asia, Europe and the South and Central Americas,  Dr. Chatoor has spoken to pediatricians, gastroenterologists, psychologists and psychiatrists about children's feeding problems. Published author of "Diagnosis and Treatment of Feeding Disorders" and "When You're Child Won't Eat or Eats Too Much," Dr. Chatoor also contributed to an article entitled, "A practical approach to classifying and managing feeding difficulties."

Throughout the course of her education and training, Dr. Chatoor attained her Medical degree at the University of Heidelberg. She then went on to complete both her residency and fellowship in Pediatrics at Children's National Medical Center through George Washington University. Later, Dr. Chatoor would then go on to complete an additional residency in Psychiatry at George Washington University and spent a transitional year completing an Internship at Providence Hospital.
To further her professional development, Dr. Chatoor is a member of the American Board of Psychiatry and Neurology and the American Board of Pediatrics.

Board certified in the areas of Psychiatry, Pediatrics and Child Psychiatry, Dr. Chatoor holds a medical license for Washington, D.C. and Maryland.

When not working, Dr. Chatoor enjoys writing.

She dedicates this recognition to the loving memory of her mother, Maria Koch.

For more information, visit www.DrChatoor.com.

Contact: Katherine Green, 516-825-5634, [email protected]

SOURCE Continental Who's Who


These press releases may also interest you

at 22:33
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

at 22:03
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

at 21:27
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

at 19:30
Astellas Pharma Inc....

at 19:15
Denver nonprofit Justice Necessary unveils data from its latest study on teen period poverty in Colorado, shedding light on a deeply concerning issue. The findings of this study underscore the urgent need for action to address the need for teens to...

at 19:05
Xaira Therapeutics launched today on a mission to help re-engineer the way we discover and develop medicines through the end-to-end application of emerging AI technologies. A joint incubation by ARCH Venture Partners and Foresite Labs, Xaira launched...



News published on and distributed by: